Delivery Order SPE2DR25D3009-SPE2DR26FWJP7
Award Date 2/23/26
Potential Completion Date 3/16/26
Potential Value $4.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a $4,268.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Ingrezza Initiation Pack for tardive dyskinesia treatment, with completion scheduled for January 28, 2026. This is a non-set-aside, competitively awarded contract with performance at the contractor's Conshohocken, Pennsylvania headquarters. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (formerly known as...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 18, 2026, with a ceiling value of $3,874.06 for supply of Ingrezza 40 mg capsules (30-count units). Place of performance is Conshohocken, PA. The order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999 and running through December 2026. Ultimate completion date for this delivery order is March 11, 2026. Pricing is firm fixed price...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) on September 18, 2025, with an ultimate completion date of October 9, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count) on August 12, 2025, with a ceiling value of $4,027.70 and an ultimate completion date of September 3, 2025. This non-set-aside, firm fixed-price delivery order represents a competitive award to the pharmaceutical distributor for a neurological medication used in the treatment of tardive dyskinesia. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Ingrezza 40 mg capsules (30-count units) with a ceiling value of $7,748.14. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to the prime contractor. The order is scheduled for completion by November 25, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,874.06 to AmerisourceBergen Drug Corp for 30 capsules of Ingrezza 40 mg, a medication used to treat involuntary movements associated with tardive dyskinesia. This non-set-aside, competitively awarded contract was executed on December 30, 2025, with an ultimate completion date of January 22, 2026. The delivery order is performed at the contractor's location in Conshohocken, Pennsylvania, where the company maintains its corporate...
- <p>The Defense Logistics Agency issued a $4,244.58 delivery order to AmerisourceBergen Drug Corp on February 23, 2026, for Ingrezza 80 mg capsule supply (30-count).</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is March 16, 2026. The order carries firm fixed pricing and was issued without a set-aside.</p>
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 18, 2026, for $4,244.58 (ceiling value) to supply Ingrezza 80 mg capsule 30s.</p> <p>Place of performance is Conshohocken, PA. The ultimate completion date is March 11, 2026. This is a firm fixed-price delivery order issued under no set-aside.</p>
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 10, 2026, with a ceiling value of $3,874.06 for supply of Ingrezza 40 mg capsule, 30-count units.</p> <p>Place of performance is Conshohocken, PA. The order has an ultimate completion date of March 4, 2026. Pricing is firm fixed price under a non-set-aside competitive award.</p>
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,027.70 for Ingrezza 80 mg capsules (30-count units) on July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ingrezza is a prescription medication used to treat tardive dyskinesia, a movement disorder, and represents...
- SPE2DR25D3009Indefinite Delivery Contract
- SPE2DR25D3009-SPE2DR26FWJP7Delivery Order
The Defense Logistics Agency issued a $4,268.43 delivery order to AmerisourceBergen Drug Corp on February 23, 2026, for Ingrezza initiation pack (tardive dyskinesia treatment), firm fixed price, with an ultimate completion date of March 16, 2026. Place of performance is Conshohocken, PA. The order carries no set-aside designation and was competitively awarded. This delivery order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026, which supports military healthcare programs globally with specialty medications, brand-name and generic drugs, vaccines, and medical supplies.
Generated 5/24/26, 9:45 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 2/22/26 |